Loading…
RGEN · NASDAQ · Biotechnology
Stock since the trade +20.8% · S&P 500 +15.4% · to Oct 5
A board member of Repligen sold $44K of Repligen shares. Nobody planned it ahead of time.
Stock since the trade +23.8% · S&P 500 +17.4% · to Oct 5
Repligen's Chief Operating Officer sold $331K of Repligen shares. Nobody planned it ahead of time.
Anthony Hunt · Traded Nov 13, 2025 · largest single filing ~$896K
Nov 13, 2025~$896K · 5,737 sh @ $156.22
DetailsOfficial recordNov 13, 2025~$466K · 3,000 sh @ $155.45
DetailsDirector sold ~$1.75M of Repligen
Scheduled in advanceDirector sold ~$777K of Repligen
Scheduled in advanceDirector sold ~$739K of Repligen
Scheduled in advanceDirector sold ~$580K of Repligen
Scheduled in advanceDirector sold ~$74K of Repligen
Scheduled in advanceNov 13, 2025~$448K · 2,923 sh @ $153.14
DetailsOfficial recordNov 13, 2025~$386K · 2,500 sh @ $154.32
DetailsOfficial recordNov 13, 2025~$320K · 2,100 sh @ $152.17
DetailsOfficial recordNov 13, 2025~$307K · 1,956 sh @ $157.11
DetailsOfficial recordNov 13, 2025~$269K · 1,784 sh @ $151.01
DetailsOfficial record